Artelo Biosciences (NASDAQ:ARTL) is expanding its development pipeline into ophthalmology with a new clinical study evaluating its drug candidate ART27.13 for the treatment of glaucoma. The San ...

Investigator-sponsored study funded by Glaucoma UK and the HSC R&D Division expands ART27.13’s clinical potential into ophthalmologyFirst ...

Artelo Biosciences (ARTL) stock jumped 40% after announcing a fully-funded glaucoma trial for ART27.13 with Belfast Health and Social Care Trust.

The charity has developed the images in collaboration with researchers at City St George’s, University of London ...

Artelo Biosciences (NASDAQ: ARTL) has announced its entry into the ophthalmology space with a fully funded clinical study evaluating ART27.13 in glaucoma patients. The investigator-sponsored trial ...

AI could revolutionise glaucoma detection. Here’s 6 things everyone should know - Age and family history are significant risk factors for developing glaucoma ...

Glaucoma UK is delighted to announce the three recipients of our 2025 project grants. The panel had a difficult time deciding between some strong applications. Associate Professor Kuang Hu (UCL ...

The number of people over 40 in the UK living with glaucoma-the leading cause of irreversible blindness worldwide-is already higher than expected and is projected to surge to more than 1.6 million by ...

Artelo Biosciences Inc (NASDAQ:ARTL) shares jumped 32.9% Wednesday following the company’s announcement of a study agreement with Belfast Health and Social Care Trust to evaluate its drug candidate ...

Specsavers is calling on eye care professionals across optometry to support a parliamentary bill aimed at tackling the growing burden of glaucoma during World Glaucoma Week (8–14 March). The multiple ...

The number of people over 40 in the UK living with glaucoma—the leading cause of irreversible blindness worldwide—is already higher than expected and is projected to surge to more than 1.6 million by ...

Over one million people are estimated to currently have glaucoma in the UK, a figure projected to reach more than 1.6 million by 2060, according to a study led by UCL and Moorfields researchers. The ...